What is the price target for YMTX stock?
9 analysts have analysed YMTX and the average price target is 35.7 USD. This implies a price increase of 1788.89% is expected in the next year compared to the current price of 1.89.
YUMANITY THERAPEUTICS INC (YMTX) Forecast, Price Target & Analyst Ratings
NASDAQ:YMTX • US98872L1026
Current stock price
1.89 USD
+0.15 (+8.62%)
At close:
1.9 USD
+0.01 (+0.53%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for YUMANITY THERAPEUTICS INC (YMTX).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Mar 22, 2023
- Period
- Q4 / 2022
- EPS Estimate
- -$1.17
- Revenue Estimate
- 3.06M
Price Target Details & History
Consensus Price Target and Range
Mean target
$35.70
Upside
+ 1,788.89%
From current price of $1.89 to mean target of $35.70, Based on 9 analyst forecasts
Low
$35.35
Median
$35.70
High
$36.75
Price Target Revisions
1 Month
0.00%
3 Months
N/A
Price Target Summary
9 Wall Street analysts provided a forecast for the next 12 months for YMTX. The average price target is 35.7 USD. This implies a price increase of 1788.89% is expected in the next year compared to the current price of 1.89.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
84.44%
YMTX was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about YMTX.
In the previous month the buy percentage consensus was at a similar level.
YMTX was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-06-04 | HC Wainwright & Co. | Initiate | Buy |
| 2021-04-01 | Jefferies | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 22, 2023
- Period
- Q4 / 2022
- EPS Estimate
- -$1.17
- Revenue Estimate
- 3.06M
- Revenue Q2Q
- 301.57%
- EPS Q2Q
- -17.30%
- Number of Analysts
- 4
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
N/A
Next Earnings Summary
YMTX is expected to report earnings on 3/22/2023. The consensus EPS estimate for the next earnings is -1.17 USD and the consensus revenue estimate is 3.06M USD.
Full Analyst Estimates 2022 - 2026
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5M 76.06% | 6.9M 38.00% | 8.044M 16.58% | 10.2M 26.80% | 12.24M 20.00% | -100.00% | |||
| EBITDA YoY % growth | -59.74M 2.70% | -54.86M 8.17% | -38.114M 30.52% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -61.15M 3.21% | -55.63M 9.03% | -38.745M 30.35% | -43.35M -11.89% | -54.06M -24.71% | -86.459M -59.93% | -48.893M 43.45% | -28.202M 42.32% | |
| Operating Margin | -1,223.00% | -806.23% | -481.66% | -425.00% | -441.67% | N/A | N/A | N/A | |
| EPS YoY % growth | -23.00 28.57% | -5.44 76.35% | -3.85 29.23% | -6.18 -60.56% | -9.80 -58.50% | -8.00 18.38% | -4.82 39.67% | -2.97 38.47% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.17 -17.30% | -1.25 -42.57% | -1.28 -183.33% | -1.26 -308.00% | -1.26 -7.83% |
| Revenue Q2Q % growth | 3.06M 301.57% | 2.55M 149.27% | 3.06M 84.67% | 3.06M 118.26% | 3.57M 16.67% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -12.24M -22.14% | -13.26M -52.45% | -13.515M -168.10% | -13.515M -285.70% | -13.77M -12.50% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-27.59%
EPS Next 5 Year
4.21%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
-14.87%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
YUMANITY THERAPEUTICS INC / YMTX Forecast FAQ
What is the next earnings date for YMTX stock?
YUMANITY THERAPEUTICS INC (YMTX) will report earnings on 2023-03-22.
What are the consensus estimates for YUMANITY THERAPEUTICS INC (YMTX) next earnings?
The consensus EPS estimate for the next earnings of YUMANITY THERAPEUTICS INC (YMTX) is -1.17 USD and the consensus revenue estimate is 3.06M USD.
How do analysts rate YUMANITY THERAPEUTICS INC (YMTX)?
The consensus rating for YUMANITY THERAPEUTICS INC (YMTX) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.